Ergomed plc announced that Neil Clark, current Chief Financial Officer (CFO) has been appointed as full time Chief Executive Officer (CEO) of Ergomed's trading subsidiary PrimeVigilance. Neil remains an Ergomed plc Board member. As a consequence of this change the Board of Ergomed announced that Stephen Stamp has been appointed as CFO and will join the Ergomed plc Board of Directors immediately.

Stephen Stamp brings to Ergomed more than 30 years of experience in corporate finance and general management in both public and private companies in the UK and the USA. Stephen joins Ergomed from AssureRx Health Inc. where he was CFO. Prior to this he was CFO of EZCORP Inc. and Chief Operating Officer and CFO at Xanodyne Pharmaceuticals Inc. He was Group Finance Director at Regus Plc.

Prior to this he was Group Finance Director at Shire Pharmaceuticals. Earlier in his career, Stephen was an investment banker with Lazard in London, advising mainly public companies on cross-border M&A and corporate finance. Prior to Lazard, he worked for KPMG in London.